Bioprocess applications of a Sindbis virus-based temperature-inducible expression system

被引:13
作者
Boorsma, M
Hoenke, S
Marrero, A
Fischer, R
Bailey, JE
Renner, WA
Bachmann, MF
机构
[1] Cytos Biotechnol AG, CH-8952 Zurich, Switzerland
[2] Swiss Fed Inst Technol, Inst Biotechnol, CH-8093 Zurich, Switzerland
[3] Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland
关键词
pCytTS; interferon; selection; recombinant protein production; inducible expression;
D O I
10.1002/bit.10311
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The production and study of toxic proteins requires inducible expression systems with low basal level expression and high inducibility. Here, we describe bioprocess applications of the pCytTS temperature-regulatable Sindbis virus replicon-based expression system. We used green fluorescent protein as a marker protein to optimize the selection of stable transfected clones with increased expression levels. Using the optimized protocol, clones were constructed that produced the growth-inhibiting, anti-viral protein interferon beta (beta-IFN). Selected clones were analyzed for temperature-dependent beta-IFN production in adherent and suspension cultures in serum free medium. Specific expression levels were around 1.0 x 10(5) IU/10(6) cells/day (0.5 mug/10(6) cells/day) in suspension cultures and over 1.5 x 10(6) IU/mL/day (7.5 mug/mL/day) in hollow fiber reactors using adherent cells. Hexahistidine-tagged beta-IFN purified from T-flask cultures was highly glycosylated and showed high specific activity. beta-IFN mRNA amplified by the viral replicase for 10 days did not show an accumulation of mutations. These data suggest the applicability of the pCytTS-inducible expression system for the production of high-quality glycoproteins in different reactors. (C) 2002 Wiley Periodicals, Inc.
引用
收藏
页码:602 / 609
页数:8
相关论文
共 39 条
  • [1] INTERFERON-BETA TREATMENT OF HUMAN-DISEASE
    ALAM, JJ
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 1995, 6 (06) : 688 - 691
  • [2] Andersen DC, 2000, BIOTECHNOL BIOENG, V70, P25, DOI 10.1002/1097-0290(20001005)70:1<25::AID-BIT4>3.0.CO
  • [3] 2-Q
  • [4] BAILEY JE, 1998, NEW DEV NEW APPL ANI, P5
  • [5] Characterization of the stability of recombinant protein production in the GS-NS0 expression system
    Barnes, LM
    Bentley, CM
    Dickson, AJ
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2001, 73 (04) : 261 - 270
  • [6] The function of type I interferons in antimicrobial immunity
    Bogdan, C
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (04) : 419 - 424
  • [7] A temperature-regulated replicon-based DNA expression system
    Boorsma, M
    Nieba, L
    Koller, D
    Bachmann, MF
    Bailey, JE
    Renner, WA
    [J]. NATURE BIOTECHNOLOGY, 2000, 18 (04) : 429 - 432
  • [8] Cointegration of DNA molecules introduced into mammalian cells by electroporation
    Chen, C
    Chasin, LA
    [J]. SOMATIC CELL AND MOLECULAR GENETICS, 1998, 24 (04) : 249 - 256
  • [9] EFFICIENT CONSTITUTIVE PRODUCTION OF HUMAN FIBROBLAST INTERFERON BY HAMSTER-CELLS TRANSFORMED WITH THE IFN-BETA-1 GENE FUSED TO AN SV40 EARLY PROMOTER
    CHERNAJOVSKY, Y
    MORY, Y
    CHEN, L
    MARKS, Z
    NOVICK, D
    RUBINSTEIN, M
    REVEL, M
    [J]. DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1984, 3 (04): : 297 - 308
  • [10] A comparative study of the relative bioavailability of different interferon beta preparations
    Deisenhammer, F
    Mayringer, I
    Harvey, J
    Dilitz, E
    Gasse, T
    Stadlbauer, D
    Reindl, M
    Berger, T
    [J]. NEUROLOGY, 2000, 54 (11) : 2055 - 2060